Piperazine compound and pharmaceutical composition containing the compound
The present invention provides a novel compound having a superior calcium antagonism, in particular, a neuron-selective calcium antagonism. Namely, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. In the formula, Ar indicates an optionally substituted 5- to 14-membered aromatic ring etc.; the ring A indicates any one ring selected from a piperazine, a homopiperazine, a piperidine and the like; the ring B indicates an optionally substituted C 3-14 on hydrocarbon ring etc.; E indicates a single bond, a group represented by the formula —CO—, etc.; X indicates a single bond, an oxygen atom etc.; R 1 indicates a hydrogen atom, a halogen atom, a hydroxyl group etc.; and D 1 , D 2 , W 1 and W 2 are the same as or different from each other and each represents a single bond or an optionally substituted C 1-6 alkylene chain.
1. A compound represented by the following formula (I), a salt thereof or a hydrate of them:
wherein R is a hydrogen atom or a nitrile.
2. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein R is the hydrogen atom.
3. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein R is the nitrile.
4. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein the compound is selected from the group consisting of:
1-[4-cyano-5-methyl-4-(5-cyano-2-thienyl)hexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine;
1-[4-cyano-5-methyl-4-(2-thienyl)hexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine;
1-(4-cyano-5-methyl-4-(3-cyano-2-thienyl)hexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine; and
1-[4-cyano-4-(3-cyano-5-thienyl)-5-methylhexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine.
5. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein the compound is selected from the group consisting of:
1-[4-cyano-5-methyl-4-(5-cyano-2-thienyl)hexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine;
1-[4-cyano-5-methyl-4-(3-cyano-2-thienyl)hexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine; and
1-[4-cyano-4-(3-cyano-5-thienyl)-5-methylhexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine.
6. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein the compound is 1-[4-cyano-5-methyl-4-(5-cyano-2-thienyl)hexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine.
7. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein the compound is 1-[4-cyano-5-methyl-4-(2-thienyl)hexyl]-4-[2-(3-cyanophenoxy) ethyl]piperazine.
8. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein the compound is 1-[4-cyano-5-methyl-4-(3-cyano-2-thienyl)hexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine.
9. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein the compound is 1-[4-cyano-4-(3-cyano-5-thienyl)-5-methylhexyl]-4-[2-(3-cyanophenoxy)ethyl]piperazine.
10. A pharmaceutical composition comprising:
the compound of claim 1 , or the salt thereof or the hydrate of them; and
a pharmaceutically acceptable carrier.
11. The pharmaceutical composition of claim 10 , wherein said pharmaceutical composition further comprises at least one ingredient selected from the group consisting of an excipient, binder, disintegrant, lubricant, colorant, flavoring agent, stabilizer, emulsifier, absorption accelerator, surfactant, pH regulator, antiseptic and antioxidant.
12. A method for suppressing a neural cell death or protecting cerebral neural cell, said method comprising: administering a pharmacologically effective amount of the compound according to claim 1 , a salt thereof, or a hydrate of them.
13. A method for treating or improving cerebral ischemia, or for treating pain, wherein said method comprises: applying an effective amount of the compound according to claim 1 to a patient in need thereof.
14. A method for treating pain, wherein said method comprises: applying pharmacologically effective amount of the compound according to claim 1 , a salt thereof, or a hydrate of them to a patient in need thereof.
15. A method for inhibiting the death of neural cells or for protecting cerebral neural cells, wherein said method comprises:
applying an effective amount of the composition of claim 10 to a patient in need thereof.
16. A method for treating or improving cerebral ischemia, or for treating pain, wherein said method comprises: applying an effective amount of the composition of claim 10 to a patient in need thereof.